Picture of Prophase Labs logo

PRPH Prophase Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Prophase Labs Inc reports results for the quarter ended in December - Earnings Summary

* Prophase Labs Inc  PRPH.OQ  reported a quarterly adjusted
loss
of 12 cents​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was
for earnings of 3 cents per share.
    * Revenue fell 51.7% to $21.83 million from a year ago;
analysts
expected $20.51 million. 
    * Prophase Labs Inc's reported EPS for the quarter was a
loss
of 12 cents​.
    * The mean earnings estimate of analysts had risen by
about 25% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Prophase Labs Inc shares had fallen by 15.3% this quarter.
    * The company reported a quarterly loss of $2.45 million.
    * Wall Street's median 12-month price target for Prophase
Labs Inc
is $15.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 28 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.03           -0.12          Missed
 Sep. 30 2022      0.19           0.06           Missed
 Jun. 30 2022      0.18           0.40           Beat
 Mar. 31 2022      0.39           0.68           Beat

Recent news on Prophase Labs

See all news